Back

State of the Art - Genetic testing in dilated cardiomyopathy

3 September 2019 (11:00 - 11:18)
Organised by:
Congress Presentation Part of: The potential of genetic testing in dilated cardiomyopathy Valvular Heart Disease ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Christine E Seidman

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
Novel insights into desminopathy in the era of next generation sequencing
Doctor M. Kubanek (Prague, CZ)
Abstract
Presentation thumbnail
Predictors of adverse cardiovascular events in patients with truncating variants in the filamin c (flnc) gene.
Doctor M. Akhtar (London, GB)
Abstract Slides Video
Presentation thumbnail
New risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies
Doctor K. Wahbi (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology.
Professor A. Bondue (Brussels, BE)
Slides Video

Access the full session

Session thumbnail
The potential of genetic testing in dilated cardiomyopathy

The Event

Event poster

ESC Congress 2019

3 September 2019 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Impact of genetic testing on the management in patients with idiopathic dilated cardiomyopathy
30 June 2021
thumbnail
Congress Session
It’s all about genetics
17 May 2025
thumbnail
Congress Presentation
Who should be prioritized for screening for adult onset dilated cardiomyopathy among first degree relatives?
2 September 2024
thumbnail
Congress Session
Cardiogenetics in everyday practice
23 June 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources